GI便検査の世界市場レポート 2025年

GI便検査市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.3％で、18億7,000万米ドルに成長します。予測期間の成長は、効率的な診断機器に対する需要の増加、大腸がんの有病率の上昇、ヘルスケア支出の増加、ファストフードの消費の増加、個別化医療への注目の高まりなどに起因すると考えられます。予測期間における主な動向としては、診断技術の革新、分子診断学の進歩、生物製剤の進歩、個別化医療の台頭、戦略的提携などが挙げられます。

消化器疾患の有病率の増加は、近い将来のGI便検査市場の成長を牽引すると予想されます。胃腸障害には、胃、腸、関連臓器などの消化器系に影響を及ぼし、吐き気、下痢、便秘、腹痛などの症状を引き起こす疾患が含まれます。このような疾患の増加は主に、加工食品の消費増加、砂糖の多量摂取、低繊維食などの食生活の乱れに起因しています。これらの要因は腸内細菌叢を乱し、消化器系の健康を損ない、酸逆流、過敏性腸症候群（IBS）、炎症性腸疾患（IBD）などの症状の一因となります。GI便検査は、病原体（細菌、ウイルス、寄生虫）、腸の炎症マーカー、消化酵素の欠乏を検出することにより、感染症、炎症、消化器系の不均衡を特定するのに役立つため、これらの疾患の診断に不可欠です。これにより、正確な診断と的を絞った治療が可能になります。例えば、2024年9月、米国疾病予防管理センター（CDC）は、2024年から2025年の間にNoroSTAT参加州で1,676件のノロウイルス集団感染が発生したと報告し、前年の同時期に記録された729件から大幅な増加を示しました。このように、胃腸疾患の有病率の上昇がGI便検査市場の成長を促進しています。

ヘルスケアインフラの拡大は、GI便検査市場の成長をさらに促進すると予想されています。ヘルスケアインフラには、病院、診療所、機器、デジタルヘルスシステムなど、医療サービスを提供するために必要な物理的、技術的、組織的システムが含まれます。このインフラの拡大は、人口の増加と高齢化によって推進されています。平均寿命が延び、疾病の有病率が高くなると、十分な医療アクセスと患者の転帰の改善を確保するために、より多くの医療施設が必要となるからです。ヘルスケア・インフラの強化は、高度な検査施設、診断技術、よりよく訓練された医療専門家を提供することにより、GI便検査へのアクセス性と有効性を向上させる。その結果、消化器疾患がより迅速かつ正確に発見され、タイムリーな治療と患者の転帰改善が可能になります。例えば、2024年11月、英国を拠点とする独立系慈善団体The Health Foundationは、保健社会福祉省の支出は、2023/24年の2,276億米ドルから、2024/25年には2,386億米ドル、2025/26年には2,506億米ドルに増加する見込みであり、年平均実質3.3％の成長を反映していると報告しています。このように、ヘルスケア・インフラの拡大はGI便検査市場の成長を支えています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界GI便検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のGI便検査市場：成長率分析
• 世界のGI便検査市場の実績：規模と成長, 2019-2024
• 世界のGI便検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界GI便検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のGI便検査市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫測定検査
• 分子診断検査
• クロマトグラフィーベースのテスト
• 微生物学的培養検査
• 酵素免疫測定（ELISA）
• 世界のGI便検査市場サンプルタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 糞便サンプル
• 血清サンプル
• 世界のGI便検査市場：機器別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動分析装置
• ベンチトップ機器
• ポータブルデバイス
• 世界のGI便検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 胃腸疾患の診断
• 大腸がんのスクリーニング
• 炎症性腸疾患（IBD）のモニタリング
• 胃腸感染症の検出
• 消化器系の健康状態の評価
• 世界のGI便検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断センターおよび検査室
• 学術機関
• 研究センター組織
• ホームケア
• その他のエンドユーザー
• 世界のGI便検査市場免疫測定検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 迅速免疫測定
• ラテラルフローアッセイ
• 蛍光免疫測定
• 世界のGI便検査市場分子診断検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応（PCR）
• 核酸増幅検査（NAAT）
• 次世代シーケンシング（NGS）
• 世界のGI便検査市場クロマトグラフィーベースのテストの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ガスクロマトグラフィー（GC）
• 液体クロマトグラフィー（LC）
• 薄層クロマトグラフィー（TLC）
• 世界のGI便検査市場微生物培養検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 好気性培養
• 嫌気性培養
• 選択的メディア文化
• 世界のGI便検査市場酵素免疫測定（ELISA）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接ELISA
• 間接ELISA
• サンドイッチELISA
• 競合ELISA

第7章 地域別・国別分析

• 世界のGI便検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のGI便検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• GI便検査市場：競合情勢
• GI便検査市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Biomerieux SA Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Meridian BioScience Inc.
• Diasorin SPA
• Helena Laboratories Corporation
• ELITechGroup
• Genova Diagnostics Inc.
• Genesis Laboratory Management LLC
• US BioTek Laboratories LLC
• Doctor's Data Inc.
• Diagnostic Solutions Laboratory LLC
• Serosep Ltd.
• Atlas Laboratories Ltd.
• VDI Laboratory LLC
• Functional Medical Institute Pvt. Ltd.
• Walk-In Lab LLC
• ScheBo Biotech AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• GI便検査市場2029：新たな機会を提供する国
• GI便検査市場2029：新たな機会を提供するセグメント
• GI便検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Gastrointestinal (GI) stool testing involves analyzing stool samples to evaluate gastrointestinal health, detect infections, digestive disorders, and inflammatory conditions. It aids in identifying microbial imbalances, digestive enzyme deficiencies, and markers of gut inflammation, making it a non-invasive diagnostic tool for early disease detection and personalized treatment planning.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of GI stool tests include immunoassay tests, molecular diagnostic tests, chromatography-based tests, microbiological culture tests, and enzyme-linked immunosorbent assay (ELISA). An immunoassay test is a diagnostic method that uses antibodies to identify specific antigens or proteins in stool samples. It can use both fecal and serum samples and requires various types of equipment, including automated analyzers, benchtop instruments, and portable devices. Immunoassay tests are used for diagnosing gastrointestinal disorders, screening for colorectal cancer, monitoring inflammatory bowel disease (IBD), detecting gastrointestinal infections, and evaluating digestive health. These tests are employed by hospitals, diagnostic centers and laboratories, academic institutions, research organizations, home care settings, and others.

The GI stool testing market research report is one of a series of new reports from The Business Research Company that provides GI stool testing market statistics, including GI stool testing industry global market size, regional shares, competitors with a GI stool testing market share, detailed GI stool testing market segments, market trends and opportunities, and any further data you may need to thrive in the GI stool testing industry. This GI stool testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The GI stool testing market size has grown strongly in recent years. It will grow from$1.32 billion in 2024 to $1.41 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period can be attributed to the rising prevalence of gastrointestinal diseases, increasing awareness of gut health, greater adoption of automated systems, growing disposable income, and the expanding geriatric population.

The GI stool testing market size is expected to see strong growth in the next few years. It will grow to$1.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing demand for efficient diagnostic instruments, the rising prevalence of colorectal cancer, higher healthcare expenditure, growing consumption of fast food, and an increasing focus on personalized medicine. Major trends in the forecast period include innovations in diagnostic technologies, advancements in molecular diagnostics, progress in biologics, the rise of personalized medicine, and strategic collaborations.

The growing prevalence of gastrointestinal disorders is anticipated to drive the growth of the GI stool testing market in the near future. Gastrointestinal disorders encompass conditions that affect the digestive system, including the stomach, intestines, and related organs, leading to symptoms such as nausea, diarrhea, constipation, and abdominal pain. The rise in such disorders is mainly attributed to poor dietary habits, including increased consumption of processed foods, high sugar intake, and low-fiber diets. These factors disrupt gut microbiota, impair digestive health, and contribute to conditions such as acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). GI stool testing is essential for diagnosing these conditions as it helps identify infections, inflammation, or digestive imbalances by detecting pathogens (bacteria, viruses, parasites), markers of gut inflammation, and digestive enzyme deficiencies. This enables accurate diagnosis and targeted treatment. For example, in September 2024, the Centers for Disease Control and Prevention (CDC) reported 1,676 norovirus outbreaks in NoroSTAT-participating states between 2024 and 2025, marking a significant increase from the 729 outbreaks recorded during the same period the previous year. Thus, the rising prevalence of gastrointestinal disorders is fueling the growth of the GI stool testing market.

The expansion of healthcare infrastructure is expected to further propel the growth of the GI stool testing market. Healthcare infrastructure includes the physical, technological, and organizational systems needed to deliver medical services, such as hospitals, clinics, equipment, and digital health systems. The expansion of this infrastructure is driven by increasing populations and aging demographics, as longer life expectancies and a higher prevalence of diseases necessitate more medical facilities to ensure adequate healthcare access and improved patient outcomes. Enhanced healthcare infrastructures improve the accessibility and effectiveness of GI stool testing by providing advanced laboratory facilities, diagnostic technologies, and better-trained medical professionals. This leads to faster and more accurate detection of gastrointestinal disorders, enabling timely treatment and better patient outcomes. For instance, in November 2024, The Health Foundation, a UK-based independent charity, reported that the Department of Health and Social Care's spending is expected to increase from $227.6 billion in 2023/24 to $238.6 billion in 2024/25, and $250.6 billion in 2025/26, reflecting an average annual real-term growth of 3.3%. As such, the expansion of healthcare infrastructure supports the growth of the GI stool testing market.

Leading companies in the GI stool testing market are prioritizing advanced diagnostic technologies, such as comprehensive tests, to improve accuracy, speed, and early detection of diseases. Comprehensive diagnostic tests evaluate multiple health parameters at once, offering a thorough assessment of a condition. For example, in November 2024, EmeritusDX, a US-based diagnostics company, launched GI Detect, a comprehensive diagnostic test designed to assist healthcare providers in diagnosing gastrointestinal disorders. This innovative test uses a single stool swab to detect 26 bacteria, viruses, and parasites associated with digestive system disturbances. With a 24-hour turnaround time, GI Detect allows for fast and informed clinical decision-making. In addition to broad pathogen detection, the test screens for Helicobacter pylori and its virulence factors-VacA, cagA, and babA-along with common gastrointestinal parasites such as Cryptosporidium, Entamoeba histolytica, and Giardia lamblia. This comprehensive approach ensures accurate and timely diagnosis of gastrointestinal infections.

Major players in the GI stool testing market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Meridian BioScience Inc., Diasorin SPA, Helena Laboratories Corporation, ELITechGroup, Genova Diagnostics Inc., Genesis Laboratory Management LLC, US BioTek Laboratories LLC, Doctor's Data Inc., Diagnostic Solutions Laboratory LLC, Serosep Ltd., Atlas Laboratories Ltd., VDI Laboratory LLC, Functional Medical Institute Pvt. Ltd., Walk-In Lab LLC, and ScheBo Biotech AG.

North America was the largest region in the GI stool testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in GI stool testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the GI stool testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The GI stool testing market consists of revenues earned by entities by providing services such as microbiome analysis, pathogen detection, colorectal cancer screening, digestive health assessment, and inflammatory marker testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The GI stool testing market also includes sales of stool test kits, reagent solutions, sample collection devices, diagnostic analyzers, and laboratory consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

GI Stool Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gi stool testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gi stool testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gi stool testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Immunoassay Test; Molecular Diagnostic Test; Chromatography-Based Test; Microbiological Culture Test; Enzyme-Linked Immunosorbent Assay (ELISA)
• 2) By Sample Type: Fecal Samples; Serum Samples
• 3) By Equipment: Automated Analyzers; Benchtop Instruments; Portable Devices
• 4) By Application: Diagnosis Of Gastrointestinal Disorders; Screening For Colorectal Cancer; Monitoring Of Inflammatory Bowel Disease (IBD); Detection Of Gastrointestinal Infections; Evaluation Of Digestive Health
• 5) By End User: Hospital; Diagnostic Centre And Laboratory; Academic Institution; Research Centre Organization; Homecare; Other End Users
• Subsegments:
• 1) By Immunoassay Test: Rapid Immunoassay; Lateral Flow Assay; Fluorescent Immunoassay
• 2) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Test (NAAT); Next-Generation Sequencing (NGS)
• 3) By Chromatography-Based Test: Gas Chromatography (GC); Liquid Chromatography (LC); Thin-Layer Chromatography (TLC)
• 4) By Microbiological Culture Test: Aerobic Culture; Anaerobic Culture; Selective Media Culture
• 5) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA; Indirect ELISA; Sandwich ELISA; Competitive ELISA
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Hologic Inc.; Biomerieux SA; Bio-Rad Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. GI Stool Testing Market Characteristics

3. GI Stool Testing Market Trends And Strategies

4. GI Stool Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global GI Stool Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global GI Stool Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global GI Stool Testing Market Growth Rate Analysis
• 5.4. Global GI Stool Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global GI Stool Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global GI Stool Testing Total Addressable Market (TAM)

6. GI Stool Testing Market Segmentation

• 6.1. Global GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Test
• Molecular Diagnostic Test
• Chromatography-Based Test
• Microbiological Culture Test
• Enzyme-Linked Immunosorbent Assay (ELISA)
• 6.2. Global GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fecal Samples
• Serum Samples
• 6.3. Global GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Analyzers
• Benchtop Instruments
• Portable Devices
• 6.4. Global GI Stool Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnosis Of Gastrointestinal Disorders
• Screening For Colorectal Cancer
• Monitoring Of Inflammatory Bowel Disease (IBD)
• Detection Of Gastrointestinal Infections
• Evaluation Of Digestive Health
• 6.5. Global GI Stool Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Diagnostic Centre And Laboratory
• Academic Institution
• Research Centre Organization
• Homecare
• Other End Users
• 6.6. Global GI Stool Testing Market, Sub-Segmentation Of Immunoassay Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rapid Immunoassay
• Lateral Flow Assay
• Fluorescent Immunoassay
• 6.7. Global GI Stool Testing Market, Sub-Segmentation Of Molecular Diagnostic Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR)
• Nucleic Acid Amplification Test (NAAT)
• Next-Generation Sequencing (NGS)
• 6.8. Global GI Stool Testing Market, Sub-Segmentation Of Chromatography-Based Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gas Chromatography (GC)
• Liquid Chromatography (LC)
• Thin-Layer Chromatography (TLC)
• 6.9. Global GI Stool Testing Market, Sub-Segmentation Of Microbiological Culture Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aerobic Culture
• Anaerobic Culture
• Selective Media Culture
• 6.10. Global GI Stool Testing Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct ELISA
• Indirect ELISA
• Sandwich ELISA
• Competitive ELISA

7. GI Stool Testing Market Regional And Country Analysis

• 7.1. Global GI Stool Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global GI Stool Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific GI Stool Testing Market

• 8.1. Asia-Pacific GI Stool Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China GI Stool Testing Market

• 9.1. China GI Stool Testing Market Overview
• 9.2. China GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India GI Stool Testing Market

• 10.1. India GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan GI Stool Testing Market

• 11.1. Japan GI Stool Testing Market Overview
• 11.2. Japan GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia GI Stool Testing Market

• 12.1. Australia GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia GI Stool Testing Market

• 13.1. Indonesia GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea GI Stool Testing Market

• 14.1. South Korea GI Stool Testing Market Overview
• 14.2. South Korea GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe GI Stool Testing Market

• 15.1. Western Europe GI Stool Testing Market Overview
• 15.2. Western Europe GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK GI Stool Testing Market

• 16.1. UK GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany GI Stool Testing Market

• 17.1. Germany GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France GI Stool Testing Market

• 18.1. France GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy GI Stool Testing Market

• 19.1. Italy GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain GI Stool Testing Market

• 20.1. Spain GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe GI Stool Testing Market

• 21.1. Eastern Europe GI Stool Testing Market Overview
• 21.2. Eastern Europe GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia GI Stool Testing Market

• 22.1. Russia GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America GI Stool Testing Market

• 23.1. North America GI Stool Testing Market Overview
• 23.2. North America GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA GI Stool Testing Market

• 24.1. USA GI Stool Testing Market Overview
• 24.2. USA GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada GI Stool Testing Market

• 25.1. Canada GI Stool Testing Market Overview
• 25.2. Canada GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America GI Stool Testing Market

• 26.1. South America GI Stool Testing Market Overview
• 26.2. South America GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil GI Stool Testing Market

• 27.1. Brazil GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East GI Stool Testing Market

• 28.1. Middle East GI Stool Testing Market Overview
• 28.2. Middle East GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa GI Stool Testing Market

• 29.1. Africa GI Stool Testing Market Overview
• 29.2. Africa GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. GI Stool Testing Market Competitive Landscape And Company Profiles

• 30.1. GI Stool Testing Market Competitive Landscape
• 30.2. GI Stool Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Biomerieux SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. GI Stool Testing Market Other Major And Innovative Companies

• 31.1. Meridian BioScience Inc.
• 31.2. Diasorin SPA
• 31.3. Helena Laboratories Corporation
• 31.4. ELITechGroup
• 31.5. Genova Diagnostics Inc.
• 31.6. Genesis Laboratory Management LLC
• 31.7. US BioTek Laboratories LLC
• 31.8. Doctor's Data Inc.
• 31.9. Diagnostic Solutions Laboratory LLC
• 31.10. Serosep Ltd.
• 31.11. Atlas Laboratories Ltd.
• 31.12. VDI Laboratory LLC
• 31.13. Functional Medical Institute Pvt. Ltd.
• 31.14. Walk-In Lab LLC
• 31.15. ScheBo Biotech AG

32. Global GI Stool Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The GI Stool Testing Market

34. Recent Developments In The GI Stool Testing Market

35. GI Stool Testing Market High Potential Countries, Segments and Strategies

• 35.1 GI Stool Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 GI Stool Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 GI Stool Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34862_GI_Stool_Testing_GMR_2025